Skip to main content
. 2023 Jun 23;22:147. doi: 10.1186/s12933-023-01882-9

Table 2.

Hazard ratios for cardiovascular events

All
(n = 138)
Patients without any cardiovascular events between two admissions
(n = 107)
Patients without a history of cardiovascular events before admission 1
(n = 98)
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Combined cardiovascular events
Unadjusted 0.49 (0.290.83) 0.009 0.39 (0.180.84) 0.02 0.53 (0.26–1.09) 0.08
Model 1 0.44 (0.260.76) 0.003 0.34 (0.160.75) 0.01 0.43 (0.210.90) 0.03
Model 2 0.51 (0.290.88) 0.02 0.39 (0.180.88) 0.02 0.43 (0.200.94) 0.03
Model 3 0.50 (0.280.87) 0.02 0.37 (0.160.86) 0.02 0.41 (0.190.90) 0.03
Heart disease
Unadjusted 0.67 (0.36–1.23) 0.19 0.57 (0.25–1.32) 0.19 0.90 (0.36–2.21) 0.81
Model 1 0.65 (0.35–1.19) 0.16 0.54 (0.23–1.27) 0.16 0.85 (0.34–2.11) 0.85
Model 2 0.75 (0.40–1.41) 0.37 0.65 (0.27–1.56) 0.33 0.77 (0.29–1.99) 0.58
Model 3 0.76 (0.40–1.43) 0.39 0.64 (0.25–1.61) 0.34 0.76 (0.29–2.01) 0.59
Stroke
Unadjusted 0.47 (0.18–1.21) 0.12 NA NA 0.61 (0.17–2.15) 0.44
Model 1 0.41 (0.16–1.08) 0.07 NA NA 0.41 (0.11–1.53) 0.19
Model 2 0.55 (0.20–1.53) 0.25 NA NA 0.45 (0.11–1.82) 0.26
Model 3 0.54 (0.20–1.49) 0.24 NA NA 0.31 (0.07–1.31) 0.11
Death
Unadjusted 0.48 (0.20–1.19) 0.11 0.47 (0.16–1.40) 0.17 0.61 (0.16–2.28) 0.46
Model 1 0.32 (0.120.84) 0.02 0.32 (0.09–1.10) 0.07 0.36 (0.08–1.50) 0.16
Model 2 0.35 (0.130.92) 0.03 0.33 (0.09–1.17) 0.09 0.36 (0.08–1.64) 0.19
Model 3 0.35 (0.130.93) 0.04 0.31 (0.08–1.14) 0.08 0.27 (0.06–1.24) 0.09

NA = not applicable (the number of cases is below 10)

HRs = hazard ratios, CI = confidence interval

HRs and 95% CI for the outcomes in the continuous low MG-H1 group compared with those of others

Model 1 includes adjustments for the following potential confounders: age, sex, and current smoking

Model 2 includes adjustments for the potential confounders of model 1 plus dyslipidemia, hypertension, diabetes duration, and obesity

Model 3 includes adjustments for the potential confounders of models 1 and 2 plus glycated hemoglobin and eGFR.